Literature DB >> 25335776

Antidepressant, antipsychotic and psychological interventions in subjects at high clinical risk for psychosis: OASIS 6-year naturalistic study.

P Fusar-Poli1, M Frascarelli1, L Valmaggia1, M Byrne1, D Stahl1, M Rocchetti1, L Codjoe1, L Weinberg1, S Tognin1, L Xenaki1, P McGuire1.   

Abstract

BACKGROUND: Recent randomized controlled trials suggest some efficacy for focused interventions in subjects at high risk (HR) for psychosis. However, treating HR subjects within the real-world setting of prodromal services is hindered by several practical problems that can significantly make an impact on the effect of focused interventions.
METHOD: All subjects referred to Outreach and Support in South London (OASIS) and diagnosed with a HR state in the period 2001-2012 were included (n = 258). Exposure to focused interventions was correlated with sociodemographic and clinical characteristics at baseline. Their association with longitudinal clinical and functional outcomes was addressed at follow-up.
RESULTS: In a mean follow-up time of 6 years (s.d. = 2.5 years) a transition risk of 18% was observed. Of the sample, 33% were treated with cognitive behavioural therapy (CBT) only; 17% of subjects received antipsychotics (APs) in addition to CBT sessions. Another 17% of subjects were prescribed with antidepressants (ADs) in addition to CBT. Of the sample, 20% were exposed to a combination of interventions. Focused interventions had a significant relationship with transition to psychosis. The CBT + AD intervention was associated with a reduced risk of transition to psychosis, as compared with the CBT + AP intervention (hazards ratio = 0.129, 95% confidence interval 0.030-0.565, p = 0.007).
CONCLUSIONS: There were differential associations with transition outcome for AD v. AP interventions in addition to CBT in HR subjects. These effects were not secondary to baseline differences in symptom severity.

Entities:  

Keywords:  schizophrenia

Mesh:

Substances:

Year:  2014        PMID: 25335776     DOI: 10.1017/S003329171400244X

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  23 in total

1.  Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.

Authors:  Barnaby Nelson; G Paul Amminger; Hok Pan Yuen; Nicky Wallis; Melissa J Kerr; Lisa Dixon; Cameron Carter; Rachel Loewy; Tara A Niendam; Martha Shumway; Sarah Morris; Julie Blasioli; Patrick D McGorry
Journal:  Early Interv Psychiatry       Date:  2017-07-18       Impact factor: 2.732

2.  Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis.

Authors:  Cathy Davies; Andrea Cipriani; John P A Ioannidis; Joaquim Radua; Daniel Stahl; Umberto Provenzani; Philip McGuire; Paolo Fusar-Poli
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

Review 3.  Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model.

Authors:  Felipe V Gomes; Millie Rincón-Cortés; Anthony A Grace
Journal:  Neurosci Biobehav Rev       Date:  2016-05-24       Impact factor: 8.989

4.  Duration of the psychosis prodrome.

Authors:  Albert R Powers; Jean Addington; Diana O Perkins; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Daniel H Mathalon; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan; Scott W Woods
Journal:  Schizophr Res       Date:  2019-12-02       Impact factor: 4.939

5.  Negative Symptom Interventions in Youth at Risk of Psychosis: A Systematic Review and Network Meta-analysis.

Authors:  Daniel J Devoe; Aaron Peterson; Jean Addington
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

6.  Real-World Clinical Outcomes Two Years After Transition to Psychosis in Individuals at Clinical High Risk: Electronic Health Record Cohort Study.

Authors:  Paolo Fusar-Poli; Andrea De Micheli; Rashmi Patel; Lorenzo Signorini; Syed Miah; Thomas Spencer; Philip McGuire
Journal:  Schizophr Bull       Date:  2020-04-18       Impact factor: 9.306

7.  A Severity-Based Clinical Staging Model for the Psychosis Prodrome: Longitudinal Findings From the New York Recognition and Prevention Program.

Authors:  Ricardo E Carrión; Christoph U Correll; Andrea M Auther; Barbara A Cornblatt
Journal:  Schizophr Bull       Date:  2017-01       Impact factor: 9.306

8.  Further evidence that antipsychotic medication does not prevent long-term psychosis in higher-risk individuals.

Authors:  JunJie Wang; TianHong Zhang; LiHua Xu; YanYan Wei; XiaoChen Tang; YeGang Hu; HuiRu Cui; YingYing Tang; ChunBo Li; Zheng Ling; JiJun Wang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-09-18       Impact factor: 5.270

9.  Prognostic Accuracy of DSM-5 Attenuated Psychosis Syndrome in Adolescents: Prospective Real-World 5-Year Cohort Study.

Authors:  Martina Maria Mensi; Silvia Molteni; Melanie Iorio; Eleonora Filosi; Elena Ballante; Umberto Balottin; Paolo Fusar-Poli; Renato Borgatti
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 9.306

10.  Diagnostic and Prognostic Significance of DSM-5 Attenuated Psychosis Syndrome in Services for Individuals at Ultra High Risk for Psychosis.

Authors:  Paolo Fusar-Poli; Andrea De Micheli; Marco Cappucciati; Grazia Rutigliano; Cathy Davies; Valentina Ramella-Cravaro; Dominic Oliver; Ilaria Bonoldi; Matteo Rocchetti; Lauren Gavaghan; Rashmi Patel; Philip McGuire
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 7.348

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.